Document Detail


Urotensin-II blockade with SB-611812 attenuates cardiac dysfunction in a rat model of coronary artery ligation.
MedLine Citation:
PMID:  16797584     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Expression of urotensin II (UII) is significantly elevated in the hearts of patients with congestive heart failure (CHF). Recent reports have also shown increased plasma levels of UII in patients with CHF, and these levels correlated with the severity of disease. We therefore hypothesized that blockade of UII signaling would improve cardiac function in a rat model of CHF. CHF was induced in rats by ligating the left coronary artery. Animals were randomized to either treatment with a specific UT receptor antagonist, SB-611812 (30 mg/kg/day, UID by gavage), or vehicle, starting either 30 min prior to coronary ligation (early treatment) or 10 days after ligation (delayed treatment). Treatment drug or vehicle was administered daily thereafter for 8 weeks. We measured cardiac function and evaluated the levels of mRNA expression for mediators of CHF. In addition, we evaluated UII and UT protein levels using immunohistochemistry and Western blotting. Cardiomyocyte hypertrophy was evaluated by measuring cardiomyocyte cross-sectional area. Animals with CHF showed increased UII and UT expression as evidenced by immunohistochemistry and Western blotting. Treatment with the SB-611812 significantly reduced overall mortality, left ventricular end-diastolic pressure by 72%, lung edema by 71%, right ventricular systolic pressure by 92%, central venous pressure by 59%, cardiomyocyte hypertrophy by 54%, and ventricular dilatation by 79% (P < 0.05). Therefore, blockade of the UT receptor reduced mortality and improved cardiac function in this model of myocardial infarction and CHF, suggesting an important role for UII in the pathogenesis of this condition.
Authors:
Nicolas Bousette; Fu Hu; Eliot H Ohlstein; Dashyant Dhanak; Stephen A Douglas; Adel Giaid
Related Documents :
2137704 - Ambulatory blood pressure monitoring and echocardiographic left ventricular wall thickn...
1894854 - Comparison of catheter ablation using radiofrequency versus direct current energy: biop...
2003934 - Effect of pericardium on left ventricular early filling assessed by pulsed doppler echo...
14666954 - Left ventricular mass in dippers and nondippers with newly diagnosed hypertension.
9758314 - Does aspirin interfere with the therapeutic efficacy of angiotensin-converting enzyme i...
2223274 - A randomised controlled trial of counseling in a workplace setting for coronary heart d...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't     Date:  2006-06-22
Journal Detail:
Title:  Journal of molecular and cellular cardiology     Volume:  41     ISSN:  0022-2828     ISO Abbreviation:  J. Mol. Cell. Cardiol.     Publication Date:  2006 Aug 
Date Detail:
Created Date:  2006-07-25     Completed Date:  2006-09-29     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0262322     Medline TA:  J Mol Cell Cardiol     Country:  England    
Other Details:
Languages:  eng     Pagination:  285-95     Citation Subset:  IM    
Affiliation:
Division of Cardiology, Montreal General Hospital, McGill University Health Center, Quebec, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Biological Markers / metabolism
Blood Pressure
Cell Size / drug effects
Coronary Vessels
Disease Models, Animal
Gene Expression Regulation / drug effects*
Heart Failure / blood,  complications,  pathology,  physiopathology,  prevention & control*
Humans
Ligation
Male
Myocardial Infarction / blood,  complications,  pathology,  physiopathology,  prevention & control*
Myocytes, Cardiac / metabolism,  pathology
Rats
Rats, Inbred Lew
Sulfonamides / pharmacology*
Urotensins / antagonists & inhibitors*,  blood
Ventricular Function, Left / drug effects
Chemical
Reg. No./Substance:
0/Biological Markers; 0/SB-611812; 0/Sulfonamides; 0/Urotensins; 9047-55-6/urotensin II; 98-10-2/benzenesulfonamide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cry toxin mode of action in susceptible and resistant Heliothis virescens larvae.
Next Document:  The unfolded state of the villin headpiece helical subdomain: computational studies of the role of l...